An unknown buyer agreed to acquire Revlis Biotech Co., Ltd. from Coland Holdings Limited (TSEC:4144) for TWD 70 million on March 24, 2017. Under the terms of agreement, 2 million shares shall be acquired for TWD 35 per share. In a related transaction, Coland Holdings Limited sold Hung Chun Bio-S Tech Co., Ltd., and CDIB Healthcare Fund Ltd. Central Chief Limited sold Joinsmart Biomedical Co., Ltd. The transaction is subject to approval by the relevant organization in charge in Taiwan.